If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,922.00    14.00 (0.29%)
Bid:
4,918.00
Ask:
4,922.00
Spread: 4.00 (0.081%)
Market Cap: £17.94b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

INVITATION TO PURCHASE NOTES FOR CASH

10 Mar 2016 10:09

RNS Number : 6828R
Coca-Cola HBC Finance B.V.
10 March 2016
 

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA OR TO ANY U.S. PERSON.

10 March 2016

COCA-COLA HBC FINANCE B.V. INVITATION TO PURCHASE NOTES FOR CASH: ANNOUNCEMENT OF RESULTS

On 3 March 2016, Coca-Cola HBC Finance B.V. (the "Company") launched an invitation to holders of its €600,000,000 4.250 per cent. Notes due 2016 guaranteed by Coca-Cola HBC Holdings B.V. and Coca-Cola HBC AG (the "Notes") to tender such Notes for purchase by the Company (the "Offer"), subject to applicable offer and distribution restrictions.

The Company today announces that it will (subject to satisfaction or waiver of the New Financing Condition) accept for purchase in cash an aggregate nominal amount of Notes validly tendered pursuant to the Offer equal to €214,619,000. The Purchase Price will be 102.903 per cent. of the nominal amount of the Notes. The Company will also pay an Accrued Interest Payment equal to 1.347 per cent. of the nominal amount of the Notes. A summary is set out below:

Description of the Notes

ISIN

Aggregate Nominal Amount Accepted for Purchase

Purchase Yield

Purchase Price

€600,000,000 4.250 per cent. Notes due 2016 of Coca-Cola HBC Finance B.V.

XS0466300257

€214,619,000

0.00 per cent.

102.903 per cent.

The Offer remains subject to the conditions and restrictions set out in a tender offer memorandum dated 3 March 2016 (the "Tender Offer Memorandum"). Capitalised terms used and not otherwise defined in this announcement have the meanings given in the Tender Offer Memorandum.

Subject to satisfaction of the New Financing Conditions, the expected Settlement Date for the Offer is 11 March 2016.

For Further Information

A complete description of the terms and conditions of the Offer is set out in the Tender Offer Memorandum. Further details about the transaction can be obtained from:

The Dealer Managers

Credit Suisse Securities (Europe) Limited

One Cabot Square

Canary Wharf

London E14 4QJ

United Kingdom

Telephone: +44 20 7883 8763

Attention: Liability Management Group

Email: liability.management@credit-suisse.com

 

 

Deutsche Bank AG, London Branch

Winchester House

1 Great Winchester Street

London EC2N 2DB

United Kingdom

Telephone: +44 20 7545 8011

Attention: Liability Management Group

Email: liability.management@db.com

 

Société Générale

10 Bishops Square

London E1 6EG

United Kingdom

 

Telephone: +44 20 7676 7579

Attention: Liability Management

Email: liability.management@sgcib.com

 

The Tender Agent

 

Lucid Issuer Services Limited

Tankerton Works

12 Argyle Walk

London WC1H 8HA

United Kingdom

Telephone: +44 20 7704 0880

Attention: Thomas Choquet

Email: cchbc@lucid-is.com

A copy of the Tender Offer Memorandum is available to eligible persons upon request from the Tender Agent.

DISCLAIMER

The Dealer Managers do not take responsibility for the contents of this announcement. This announcement must be read in conjunction with the Tender Offer Memorandum. No offer to acquire any Notes is being made pursuant to this announcement.

The distribution of this announcement and the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Tender Offer Memorandum come into are required by each of the Company, the Guarantors, the Dealer Managers and the Tender Agent to inform themselves about and to observe any such restrictions.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGMGMFGGKGVZM
Date   Source Headline
21st Jun 20224:28 pmRNSResult of AGM
20th Jun 20222:38 pmRNSDirector/PDMR Shareholding
8th Jun 20221:02 pmRNSAthens Exchange trading date of ordinary shares
6th Jun 20229:32 amRNSHolding(s) in Company
1st Jun 202210:02 amRNSIssue of Equity
31st May 20225:17 pmRNSLetter to shareholders
19th May 20229:20 amRNSNotice of AGM
18th May 20223:05 pmRNSDirector/PDMR Shareholding
18th May 202212:24 pmRNSHolding(s) in Company
12th May 20227:00 amRNSStrong performance despite turbulent environment
3rd May 202210:22 amRNSIssue of equity and total voting rights
3rd May 202210:05 amRNSBlock listing Interim Review
29th Apr 20221:46 pmRNSHolding(s) in Company
20th Apr 20223:03 pmRNSDirector/PDMR Shareholding
19th Apr 202210:06 amRNSNotice of Results
12th Apr 20225:38 pmRNSMove to organic reporting
1st Apr 20223:58 pmRNSDirector/PDMR Shareholding
1st Apr 20223:47 pmRNSDirector/PDMR Shareholding
1st Apr 202211:46 amRNSIssue of equity and total voting rights
23rd Mar 202212:23 pmRNSAnnual Financial Report
18th Mar 20222:02 pmRNSDirector/PDMR Shareholding
16th Mar 20223:43 pmRNSDirector/PDMR Shareholding
16th Mar 202212:56 pmRNSDirector/PDMR Shareholding
14th Mar 202210:57 amRNSDirector/PDMR Shareholding
9th Mar 20227:00 amRNSUkraine and Russia update
3rd Mar 20224:31 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSUkraine and Russia conflict update
22nd Feb 20227:00 amRNSSTRONG EXECUTION DRIVES GROWTH MOMENTUM
18th Feb 20222:45 pmRNSDirector/PDMR Shareholding
2nd Feb 20229:57 amRNSNotice of Results
1st Feb 20228:20 amRNSIssue of equity and total voting rights
25th Jan 202212:50 pmRNSCompletes acquisition of further stake in CCBCE
18th Jan 20222:20 pmRNSDirector/PDMR Shareholding
13th Jan 20228:53 amRNSCompletes acquisition of a majority stake in CCBCE
7th Jan 20222:14 pmRNSAthens Exchange trading date of ordinary shares
4th Jan 202210:55 amRNSIssue of equity and total voting rights
4th Jan 20229:54 amRNSDirector/PDMR Shareholding
31st Dec 202110:27 amRNSDirector/PDMR Shareholding
31st Dec 202110:19 amRNSDirector/PDMR Shareholding
20th Dec 20213:58 pmRNSDirector/PDMR Shareholding
20th Dec 20213:43 pmRNSDirector/PDMR Shareholding
17th Dec 20213:38 pmRNSPost 2021 AGM Shareholder Engagement
13th Dec 20213:29 pmRNSDirector/PDMR Shareholding
7th Dec 202110:29 amRNSDirector/PDMR Shareholding
1st Dec 20218:34 amRNSIssue of equity and total voting rights
18th Nov 20211:12 pmRNSDirector/PDMR Shareholding
15th Nov 20213:16 pmRNSDirector/PDMR Shareholding
15th Nov 20212:03 pmRNSDirector/PDMR Shareholding
12th Nov 20219:17 amRNSDirector/PDMR Shareholding
12th Nov 20218:45 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.